Member Info for gadgie

My Monies on Abingdon TT Complete and as stated we have already placed a large order ...perhaps NHS have been trying as per rumour mill back in the day :)

Worldwide Shortage ... Backs Against the Wall ..... UK Co Best in Class ....I don't give a **** if we are waiting approval Buy Buy Buy the Lot say's Boris ...... Just as he did with the Vaccine buy everything he said ..... Just Imagine if this was the conversation LOL

or Meduflow ..... BooHoo not messing LOL :) imagine the contacts these guys have

British Company ramped up production x4 ? just announced

Bioserve selling :
1mg = £1650
https://bioservuk.com/immunoassay-reagents-and-accessories/

So we supply Abcam with Reagents and they in turn supply Abingdon Health for their Lateral Flows ..... How much are these Reagents I think we are missing a trick as to monies already earned :
https://www.abingdonhealth.com/who-we-are/our-partners/

Now have employee's in South Africa ....
https://www.linkedin.com/search/results/people/?currentCompany=%5B%2266603846%22%5D&origin=COMPANY_PAGE_CANNED_SEARCH&page=2&sid=ARr

Now live for Individual's to register / download app ....... part of the registration states avail in App Store .......Once registered issue's unique QR Code etc
https://www.saturnpass.com

So much news coming our way this year

https://www.pointbiopharma.com/our-products/pipeline

https://www.globenewswire.com/news-release/2021/08/13/2280425/0/en/POINT-Biopharma-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Business-Update.html

Out of 18 companies Porges's team looked at, 12 are expected to have more than $20 billion in cash by the end of 2022 when excluding existing debt. Even after factoring in debt, Porges expects Pfizer, Moderna, Johnson & Johnson, Novartis and BioNTech to have net cash of more than $20 billion.

https://www.fiercepharma.com/pharma/m-a-large-biotech-pharma-companies-will-have-1-7t-firepower-for-dealmaking-2022

xmas no dobt

Download Avacta
http://learning.avactalifesciences.com/delta-app-note?utm_campaign=Covid-19&utm_medium=email&_hsmi=196114355&_hsenc=p2ANqtz--Le11Vq-s7lGDkWgZ8jtaZSaDVM7aXECnOH84N49BRa9bKXscgkZAbRiOPoazz35z9Q5wnRdKPM13cIwQ7MvacGz6dLA&utm_content=196114355&utm_source=hs_email
TEST METHOD
SARS-CoV-2 RT-PCR test
SARS-CoV-2 Delta VOC RT-PCR test
AffiDX® Rapid Antigen Test

Top Man

Bell END

Beinthelead ….what a arrogant ******* you are … so so rude !!!!

Need a good Writer come on someone launch a petition

https://petition.parliament.uk/petitions/new

Perhaps Add ..
LG Chem has successfully completed certain pre-clinical in-vivo models in the PD-L1/XT programme leading to the selection of a pre-clinical candidate for further development towards the clinic and triggering an undisclosed milestone payment.

Beinthelead … i thankyou … something is happening in the background hence the silence … we all need to keep digging and if necc go ovet old ground … how do you know it’s years away ?

1st june 2020 have they been working on this in the background all this time could this assist … imagine

Daewoong Pharmaceutical and AffyXell Therapeutics—the joint venture established in South Korea by the two companies—to develop stem cell treatments incorporating Avacta’s neutralizing Affimer therapy to treat seriously ill patients with COVID-19, and prepare to rapidly develop similar therapies for future global pandemics.

Old news but is it dead ?

https://www.genengnews.com/covid-19-candidates/avacta-group/